U.S. FDA

Episurf Medical has received initial feedback from the US FDA on the IDE application for the Episealer® knee implant

MON, JUL 30, 2018 08:30 CET Episurf Medical (NASDAQ: EPIS B) today announces that the company has received initial feedback…